1. How to Calculate Indirect Costs in Economic Evaluations

   • Bengt Liljas

   Current Opinion 01 December 2012 Pages: 1 - 7

2. Single European Currency and Monetary Union

   • Panos Kanavos

   Leading Article 01 December 2012 Pages: 9 - 20

3. An Outline For a Cost-Effectiveness Analysis of a Drug For Patients With Alzheimer’s Disease

   • Jan J.V. Busschbach
   • Werner B.F. Brouwer
   • Frans F.H. Rutten

   Review Article 01 December 2012 Pages: 21 - 34

4. Economic Aspects of Antibacterial Adverse Effects

   • Paul M. Beringer
   • Annie Wong-Beringer
   • Jay P. Rho

   Review Article 01 December 2012 Pages: 35 - 49

5. Peripheral Arterial Obliterative Disease

   • Armelle Montron
   • Eric Guignard
   • Sylvie Comte

   Original Research Article 01 December 2012 Pages: 51 - 59

6. Cost Implications of Initial Antidepressant Selection in Primary Care

   • Gregory Simon
   • Paul Fishman

   Original Research Article 01 December 2012 Pages: 61 - 70

7. Price Indices of Drugs and the Switching to New Drugs

   • Ulf-G Gerdtham
   • Magnus Johannesson
   • Freddie Henriksson

   Original Research Article 01 December 2012 Pages: 71 - 80

8. Cost Effectiveness of a Low-Molecular-Weight Heparin in Prolonged Prophylaxis Against Deep Vein Thrombosis After Total Hip Replacement

   • Bruno Detournay
   • André Planes
   • Francis Fagnani

   Original Research Article 01 December 2012 Pages: 81 - 89

9. Cefotaxime

   • Greg L. Plosker
   • Rachel H. Foster
   • Paul Benfield

   Adis Pharmacoeconomic Drug Evaluation 01 December 2012 Pages: 91 - 106

10. Economic Evaluation of Desirudin vs Heparin in Deep Vein Thrombosis Prevention after Hip Replacement Surgery

    • Lars-Åke Levin
    • Manfred Horst
    • David Bergqvist

    Original Research Article 01 December 2012 Pages: 111 - 118

11. Using Pharmacoeconomic Analysis to Make Drug Insurance Coverage Decisions

    • Aslam H. Anis
    • Tuhin Rahman
    • Martin T. Schechter

    Original Research Article 01 December 2012 Pages: 119 - 126

12. The Effect of Changes in Treatment Patterns on Drug Expenditure

    • Ulf-G. Gerdtham
    • Magnus Johannesson
    • Freddie Henriksson

    Original Research Article 01 December 2012 Pages: 127 - 134

13. Medico-Economic Analysis of Diacerein With or Without Standard Therapy in the Treatment of Osteoarthritis

    • Francis Fagnani
    • Gilles Bouvenot
    • Renée-Liliane Dreiser

    Original Research Article 01 December 2012 Pages: 135 - 146

14. Economic Evaluation of the Cardiac Insufficiency Bisoprolol Study for the Federal Republic of Germany

    • Peter K. Schädlich
    • Britta Paschen
    • Josef Georg Brecht

    Original Research Article 01 December 2012 Pages: 147 - 155

15. Clinical and Economic Comparison of Sertraline and Fluoxetine in the Treatment of Depression

    • P. Boyer
    • J.M. Danion
    • S. Troy

    Original Research Article 01 December 2012 Pages: 157 - 169